Contact tracing

2023 Norm Hardy Prize Awarded by Foresight Institute for 'Advances in Usable Security'

Retrieved on: 
Wednesday, February 14, 2024

SAN FRANCISCO, Feb. 14, 2024 /PRNewswire-PRWeb/ -- In an age where reliable computer security is critical, Foresight Institute proudly announces Covid Watch as the winner of the inaugural 2023 Norm Hardy Prize for its significant contribution to the field of usable security.

Key Points: 
  • In an age where reliable computer security is critical, Foresight Institute proudly announces Covid Watch as the winner of the inaugural 2023 Norm Hardy Prize for its significant contribution to the field of usable security.
  • SAN FRANCISCO, Feb. 14, 2024 /PRNewswire-PRWeb/ -- In an age where reliable computer security is critical, Foresight Institute proudly announces Covid Watch as the winner of the inaugural 2023 Norm Hardy Prize for its significant contribution to the field of usable security.
  • This prize celebrates work building upon the vision of the late computer scientist Norm Hardy, best known for identifying the confused deputy vulnerability.
  • Established in 1986, Foresight Institute is a leading nonprofit and public interest organization focused on emerging world-shaping technologies.

Fighting leprosy with artificial intelligence: DAHW and Belle.ai join forces with Senegal’s Ministry of Health and Social Action to detect and combat neglected diseases

Retrieved on: 
Wednesday, January 24, 2024

DAHW and Belle.ai will also provide the Ministry of Health with a geographic information system (GIS) for tracking infections and coordinating treatment response.

Key Points: 
  • DAHW and Belle.ai will also provide the Ministry of Health with a geographic information system (GIS) for tracking infections and coordinating treatment response.
  • Aiming to integrate people with leprosy into society, Senegal in June 2023 officially abolished the “social rehabilitation villages” created in 1976 to isolate people with leprosy.
  • But leprosy remains endemic in remote areas of the nation, where no dermatologists are readily available to identify the disease.
  • Artificial intelligence can help healthcare staff with less expertise to detect diseases such as leprosy in regions where no specialist personnel venture."

Global Citizen Services AI Research Report 2023 - ResearchAndMarkets.com

Retrieved on: 
Friday, December 1, 2023

The "Citizen Services AI - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Citizen Services AI - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for Citizen Services AI estimated at US$6.3 Billion in the year 2022, is projected to reach a revised size of US$90.4 Billion by 2030, growing at a CAGR of 39.5% over the analysis period 2022-2030.
  • AI has been instrumental in data analysis, drug discovery, vaccine development, and contact tracing, contributing significantly to the global response to the pandemic.
  • Various segments within the AI market, including citizen services AI, are witnessing competition among key players.

Global Citizen Services AI Business Report 2023: Market to grow at a CAGR of 39.5% to 2030 - Governments Focus on Regulations as Use of AI Continues to Grow

Retrieved on: 
Friday, December 1, 2023

DUBLIN, Nov. 30, 2023 /PRNewswire/ -- The "Citizen Services AI - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 30, 2023 /PRNewswire/ -- The "Citizen Services AI - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • AI-enabling technologies, such as advanced algorithms and computing power, play a crucial role in AI's development and application.
  • These technologies enable machines to process and analyze vast amounts of data, recognize patterns, and make predictions or recommendations.
  • Various segments within the AI market, including citizen services AI, are witnessing competition among key players.

Laboratory Testing and PCR Technology Lead the India Infectious Disease Diagnostics Market, Transforming Disease Detection and Management - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 8, 2023

The India emerging infectious disease diagnostics market is set for substantial growth over the forecast period from 2023 to 2033.

Key Points: 
  • The India emerging infectious disease diagnostics market is set for substantial growth over the forecast period from 2023 to 2033.
  • The India emerging infectious disease diagnostics market is currently in an emerging phase.
  • The India emerging infectious disease diagnostics market plays a pivotal role in modern biotechnology, clinical diagnostics, and pathogen research.
  • The India emerging infectious disease diagnostics market is segmented into key categories:
    In FY2022, laboratory testing was the dominant application segment in the India emerging infectious disease diagnostics market.

Tuberculosis isn't just a historical disease. Here's how it spreads and who is at risk

Retrieved on: 
Tuesday, October 17, 2023

Tuberculosis is often seen as a threat of the past. But it remains a significant concern worldwide, with international travel spreading the disease. While tuberculous is rare in Australia, and we no longer routinely vaccinate against it, clusters of cases in South Australia over the past 17 months have put health authorities on alert. So what exactly is tuberculosis, how is it treated and what is Australia doing to prevent its transmission? It starts as a respiratory infection Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, starts as a respiratory infection when inhaled.

Key Points: 


Tuberculosis is often seen as a threat of the past. But it remains a significant concern worldwide, with international travel spreading the disease. While tuberculous is rare in Australia, and we no longer routinely vaccinate against it, clusters of cases in South Australia over the past 17 months have put health authorities on alert. So what exactly is tuberculosis, how is it treated and what is Australia doing to prevent its transmission?

It starts as a respiratory infection

    • Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, starts as a respiratory infection when inhaled.
    • Once in the lungs, the immune system responds by forming granulomas, clusters of immune cells (mainly macrophages and T cells), in an attempt to contain the infection.

Early treatment is key

    • Early diagnosis and treatment reduces the infectious period and helps prevent spreading the disease to others.
    • Delayed treatment can lead to complications such as lung damage and scarring; damage to the bones, kidneys, lymph nodes and central nervous system; and infection in the brain and spinal cord.
    • Antibiotic treatment, often involving multiple drugs, is highly effective at eliminating the bacteria.

Tackling drug-resistant bacteria

    • The Mycobacterium tuberculosis bacteria can quickly become resistant to antibiotics, so routine treatment includes multiple antibiotics which increases adverse effects.
    • The emergence of drug-resistant tuberculosis strains is a major concern because it makes treatment significantly more challenging and costly.

Who is susceptible to tuberculosis?

    • Children are also at greater risk of tuberculosis, as their immune systems are still developing.
    • However, the World Health Organization estimates 11% of the 10.6 million tuberculosis cases worldwide are in children.
    • Some 14% of all tuberculosis-related deaths occur in children under 15 years old.

What can we do about TB?

    • The Bacille Calmette-Guérin vaccine provides partial protection, primarily against severe forms of tuberculosis.
    • It’s not routinely given in Australia because we’re not considered a high-risk country, but it’s given in local regions with tuberculosis outbreaks.
    • Visa applicants aged 11 years and over must have a chest X-ray for evidence of active tuberculosis.

Who tracked UK COVID infections the best at the height of the pandemic? A new study provides the answer

Retrieved on: 
Tuesday, October 17, 2023

We wanted to know which of these methods was the most reliable during the first two years of the pandemic.

Key Points: 
  • We wanted to know which of these methods was the most reliable during the first two years of the pandemic.
  • The gold standard surveillance was the Office for National Statistics (ONS) COVID survey.
  • This data tracked the ONS estimates very closely, though the reported numbers were usually only about 45% of the ONS data.
  • The Zoe app also tracked the ONS survey estimates closely and was a good estimate of whether infections were rising or falling.
  • For COVID, the question was can wastewater testing indicate how much infection is present in the population?
  • In our analysis, we found that counts in wastewater were moderately correlated with the prevalence of COVID in the population.

Useful additional insights

    • Even so, the other approaches provided useful additional insights.
    • NHS 111 call and website data provided useful information early in the pandemic, before other surveillance methods were established.
    • Although wastewater surveillance did little to increase our understanding of the course of the pandemic in England, this surveillance method may be useful in countries that don’t have easy access to human testing.

SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer

Retrieved on: 
Wednesday, September 6, 2023

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executive Vice President and Chief Medical Officer (CMO).

Key Points: 
  • NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executive Vice President and Chief Medical Officer (CMO).
  • He will also continue to serve as a director of the SIGA Board of Directors.
  • “In his new additional role as EVP and Chief Medical Officer, he will be positioned to apply even more of his outstanding insight and experience to support our advocacy efforts.”
    As EVP and CMO, Dr. Varma will lead medical affairs.
  • SIGA plays a central role in helping countries around the world understand and respond to potential outbreaks of smallpox, MPOX and other orthopox viruses,” said Dr. Varma.

KMOU Researchers Develop a Novel Algorithm for Mitigating COVID-19 Spread in Ships

Retrieved on: 
Tuesday, August 29, 2023

BUSAN, South Korea, Aug. 29, 2023 /PRNewswire/ -- The COVID-19 pandemic has drastically affected human lives and the global economy. In particular, cruise ship companies around the world are among the worst hit industries, with ships becoming a hotbed of viral infection owing to their confined environment. With the economy slowly recovering in the post COVID-19 period, ship companies hope to return to normal operations by adopting a sustainable management model that prioritizes the health of ship passengers.

Key Points: 
  • Tracking and physical isolation of infected passengers remains the standard protocol for preventing the spread of virus.
  • Unfortunately, an effective identification of individuals in close contacts, who have potentially been exposed to the virus and can spread it, remains challenging.
  • The researchers next conducted close contact tracing experiments on the HANNARA ship, a training vessel for KMOU.
  • Furthermore, CCIA also enhances the capabilities of user devices such as smartphones in mitigating the spread of COVID-19.

STIs are on the rise – here's how to navigate telling a partner if you've got one

Retrieved on: 
Tuesday, July 25, 2023

The number of gonorrhoea diagnoses recorded in England was in fact the highest since annual records began.

Key Points: 
  • The number of gonorrhoea diagnoses recorded in England was in fact the highest since annual records began.
  • On one hand you are being honest, responsible and respectful to your partner (or partners), and protecting their health.
  • The articles in this series explore the questions and bring answers as we navigate this turbulent period of life.
  • Letting sexual partners know if you have an STI is essential to the prevention, treatment and control of these infections.

Honesty is the best policy

    • For example, a single course of antibiotics will often clear chlamydia, gonorrhoea, syphilis and “trich” (trichomoniasis).
    • It’s totally normal to be anxious about your partner’s response and the potential effect on your relationship, whether casual or long term.
    • It’s also important to disclose if you have an STI before starting a sexual relationship with someone new.

What if a partner discloses that they have an STI?

    • When asking these questions, try to be mindful of the language you use, and avoid placing blame.
    • An early STI diagnosis is the best opportunity for effective treatment, and prevention of health complications and further transmission.
    • If you do decide to have sex, it’s advisable to use a physical barrier such as a condom or dental dam to protect your partner.

Make this an opportunity

    • Whether it’s you or your partner who have an STI – or both – use this opportunity to do some research on sexual health.
    • The COVID pandemic has also shown us the crucial role of early detection, rapid testing, and importantly, public health communication and education.
    • Overcoming STI stigma, much like COVID stigma, requires education, improving access to STI testing and treatment, and the promotion of inclusive conversations about sexual health.